ZAVESCA 100 MG CPS DUR 84
Rychlý přehled
| Dosage form | Capsules |
|---|---|
| Výdej | Ne, lék nelze získat bez receptu. |
| Úhrada / doplatek / cena | Lék, jehož použití je s ohledem na veřejný zájem účelné koncentrovat do specializovaných pracovišť dle § 15 odst. 10 zákona o veřejném zdravotním pojištění. Lék je hrazen jako ZÚLP a to pouze z pracoviště, které má smlouvu se zdravotní poj… |
| Kdo může předepsat | Prescription is not conditional on a medical specialization. |
| Složení | Miglustat (100 mg), sodná sůl karboxymethylškrobu, povidon k 30, magnesium-stearát, želatina, oxid titaničitý, šelak, černý oxid železitý. More information about the composition can be found in the SPC, section 6.1. |
| Dostupnost / výpadek | Information from SÚKL is not available. |
| Kód SÚKL | 0027034 |
What is the maximum co-payment for ZAVESCA?
If the insurance company contributes, the maximum co-payment is 0,00 Kč. The maximum pharmacy price is 67 314,56 Kč. A pharmacy may provide the medicine for a lower price, but not for a higher price.
Does the medicine have reimbursement from public health insurance?
A medicine whose use is, in the public interest, appropriate to concentrate in specialized facilities pursuant to Section 15(10) of the Public Health Insurance Act. The medicine is reimbursed as ZÚLP and only from a facility that has a contract with the health insurer.
Does ZAVESCA have a counted co-payment set?
No, this medicine has no counted co-payment.
How much does the insurance company pay for one dispensed reimbursed pack?
119 854,18 Kč.
Does the insurance company pay a higher amount in some cases?
No, the medicine has no increased reimbursement.
Does the medicine have an indication restriction?
Is it available without a medical prescription?
No, the medicine cannot be obtained without a prescription.
Which medical specialist may prescribe ZAVESCA?
Prescription is not conditional on a medical specialization.
What is the composition of ZAVESCA?
Miglustat (100 mg), sodná sůl karboxymethylškrobu, povidon k 30, magnesium-stearát, želatina, oxid titaničitý, šelak, černý oxid železitý. More information about the composition can be found in the SPC, section 6.1.
Where can I find information about correct use of the medicine?
Which medicines are similar to ZAVESCA?
The medicine belongs to ATC group A16AX06 – Miglustat. Medicines with the same active substance can be found here.
Who manufactures ZAVESCA?
JANSSEN-CILAG INTERNATIONAL N.V., BEERSE (B)
Is the medicine in shortage?
Information from SÚKL is not available.
What is the unique code for ZAVESCA?
The medicine has code 0027034. Code details can be found here.
How many packs of ZAVESCA were previously dispensed on prescriptions in Czechia?
Show prescription medicine consumption
How many packs of ZAVESCA were previously dispensed on request forms in Czechia?
Show request-form medicine consumption
Z čeho se skládá maximální cena léku?
The page was last updated on 17. 07. 2026